CAMBRIDGE, England and WALTHAM, Mass., March 30,
2023 /PRNewswire/ -- Abcam plc (Nasdaq: ABCM), a
global leader in the supply of life science research tools,
announces that, following release on 20
March 2023 of its final results for the year ended
31 December 2022 on Form 20-F with
the Securities and Exchange Commission, the Abcam plc Annual Report
and Accounts 2022 (the "Annual Report") have been published
today and are available on the Abcam plc website
at corporate.abcam.com
The Annual Report will also be posted today, together with the
Notice of Annual General Meeting, to those shareholders that have
elected to receive paper communications. Shareholders that
have not elected to receive paper communications will be notified
of the availability of these documents on Abcam plc website
at corporate.abcam.com. The Form 20-F can also be
accessed on the Abcam plc website at corporate.abcam.com.
Shareholders that have not elected to receive paper communications
may still receive a hard copy of these documents upon request.
For further information, please contact:
Abcam
Tommy Thomas, CPA, Vice President,
Investor Relations, +1 617 577 4205, tommy.thomas@abcam.com
About Abcam plc
As an innovator in reagents and tools, Abcam's purpose is to
serve life science researchers globally to achieve their mission,
faster. Providing the research and clinical communities with tools
and scientific support, the Company offers highly validated
antibodies, assays and other research tools to address important
targets in critical biological pathways.
Already a pioneer in data sharing and ecommerce in the life
sciences, Abcam's ambition is to be the most influential company in
life sciences by helping advance global understanding of biology
and causes of disease, which, in turn, will drive new treatments
and improved health.
Abcam's worldwide customer base of approximately 750,000 life
science researchers uses Abcam's antibodies, reagents, biomarkers
and assays. By actively listening to and collaborating with these
researchers, the Company continuously advances its portfolio to
address their needs. A transparent programme of customer reviews
and datasheets, combined with an industry-leading validation
initiative, gives researchers increased confidence in their
results.
Founded in 1998 and headquartered in Cambridge, UK, the Company has served
customers in more than 130 countries. Abcam's American Depositary
Shares (ADSs) trade on the Nasdaq Global Market (Nasdaq: ABCM).
For more information, please visit corporate.abcam.com.
View original
content:https://www.prnewswire.com/news-releases/abcam-plc-publication-of-2022-annual-report-and-accounts-and-notice-of-annual-general-meeting-301785708.html
SOURCE Abcam plc